Please login to the form below
Viagra
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Viagra was produced by Pfizer.
A snapshot of Healx
and Dr David Brown, co- inventor of Viagra and former Global Head of Drug Discovery at Roche.
Pfizer set to unveil Mylan merger and spin-off
Its biggest off-patent brands would include drugs such as Pfizer’s Lipitor, Viagra and Mylan’s Epipen.
The handover: Pfizer reshapes itself for a new era
autonomous. Created in the summer reshuffle, the Established Medicines division includes the majority of Pfizer’s off-patent blockbuster pills, including Lyrica, Lipitor, Norvasc and Viagra, and a number of other
Brand teams: why are some smarter than others?
They defeat powerful incumbents, like Cialis did with Viagra, or they overcome health-system conservatism, as Abbot is doing with its FreeStyle Libre device.
Prix Galien opens for entries with new award
Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Bexero, Cervarix and Gardasil.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Amgen adds Otezla to the COVID-19 candidate list
- Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
- New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
